novadiscovery is a developer of a drug discovery platform in silico clinical trials designed to de-risk, optimize research and development along with curbing the cost of discovering new drugs. Founded by Francois-Henri Boissel in 2010, Novadiscovery is backed by investors that include Sanofi, Debiopharm Group, BIG BOOSTER, and H2020 and is headquartered in Lyon.
FOUNDED:
2010
INDUSTRY:
Artificial Intelligence, Biotechnology, CRM, Health Care, Information Technology, Medical
FOUNDERS:
Francois-Henri Boissel
You are seconds away from signing up for the hottest list in New York Tech!
Join the millions and keep up with the stories shaping entrepreneurship. Sign up today.
